LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 48 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STEELHEAD PARTNERS LLC | 70,062,000 | $61,167,000 | 7.51% |
| SYMPHONY ASSET MANAGEMENT LLC | 18,000,000 | $15,668,000 | 5.06% |
| Context Capital Management, LLC | 6,350,000 | $5,569,000 | 2.17% |
| CANYON CAPITAL ADVISORS LLC | 60,000,000 | $52,680,000 | 1.76% |
| Opti Capital Management, LP | 8,500 | $7,400,000 | 1.26% |
| III Capital Management | 5,000,000 | $4,365,000 | 1.08% |
| FALCON POINT CAPITAL, LLC | 250,000 | $219,000 | 1.07% |
| Venator Capital Management Ltd. | 1,500,000 | $1,308,000 | 0.86% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 30,500,000 | $26,576,000 | 0.62% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 22,500,000 | $19,733,000 | 0.48% |